Metabolism and mitochondria in polycystic kidney disease research and therapy

V Padovano, C Podrini, A Boletta… - Nature Reviews …, 2018 - nature.com
Autosomal dominant polycystic kidney disease (ADPKD) is one of the most common,
potentially lethal, monogenic diseases and is caused predominantly by mutations in …

The cell biology of polycystic kidney disease

HC Chapin, MJ Caplan - Journal of Cell Biology, 2010 - rupress.org
Polycystic kidney disease is a common genetic disorder in which fluid-filled cysts displace
normal renal tubules. Here we focus on autosomal dominant polycystic kidney disease …

Organoid cystogenesis reveals a critical role of microenvironment in human polycystic kidney disease

NM Cruz, X Song, SM Czerniecki, RE Gulieva… - Nature materials, 2017 - nature.com
Polycystic kidney disease (PKD) is a life-threatening disorder, commonly caused by defects
in polycystin-1 (PC1) or polycystin-2 (PC2), in which tubular epithelia form fluid-filled cysts …

Defective glucose metabolism in polycystic kidney disease identifies a new therapeutic strategy

I Rowe, M Chiaravalli, V Mannella, V Ulisse, G Quilici… - Nature medicine, 2013 - nature.com
Autosomal dominant polycystic kidney disease (ADPKD) is a common genetic disorder
characterized by bilateral renal cyst formation. Recent identification of signaling cascades …

[HTML][HTML] microRNA-17 family promotes polycystic kidney disease progression through modulation of mitochondrial metabolism

S Hajarnis, R Lakhia, M Yheskel, D Williams… - Nature …, 2017 - nature.com
Autosomal dominant polycystic kidney disease (ADPKD) is the most frequent genetic cause
of renal failure. Here we identify miR-17 as a target for the treatment of ADPKD. We report …

[HTML][HTML] Defining cellular complexity in human autosomal dominant polycystic kidney disease by multimodal single cell analysis

Y Muto, EE Dixon, Y Yoshimura, H Wu… - Nature …, 2022 - nature.com
Autosomal dominant polycystic kidney disease (ADPKD) is the leading genetic cause of end
stage renal disease characterized by progressive expansion of kidney cysts. To better …

Targeting angiogenesis and lymphangiogenesis in kidney disease

K Tanabe, J Wada, Y Sato - Nature Reviews Nephrology, 2020 - nature.com
The kidney is permeated by a highly complex vascular system with glomerular and
peritubular capillary networks that are essential for maintaining the normal functions of …

[HTML][HTML] Cyst growth in ADPKD is prevented by pharmacological and genetic inhibition of TMEM16A in vivo

I Cabrita, A Kraus, JK Scholz, K Skoczynski… - Nature …, 2020 - nature.com
In autosomal dominant polycystic kidney disease (ADPKD) multiple bilateral renal cysts
gradually enlarge, leading to a decline in renal function. Transepithelial chloride secretion …

A RhoA–YAP–c-Myc signaling axis promotes the development of polycystic kidney disease

J Cai, X Song, W Wang, T Watnick, Y Pei… - Genes & …, 2018 - genesdev.cshlp.org
Autosomal dominant polycystic kidney disease (ADPKD) is an inherited disorder caused by
mutations in PKD1 or PKD2 and affects one in 500–1000 humans. Limited treatment is …

[HTML][HTML] Metabolic reprogramming and the role of mitochondria in polycystic kidney disease

C Podrini, L Cassina, A Boletta - Cellular signalling, 2020 - Elsevier
Abstract Autosomal Dominant Polycystic Kidney Disease (ADPKD) is a slowly progressive
disease characterized by the relentless growth of renal cysts throughout the life of affected …